Treatment of cystic fibrosis pulmonary exacerbation and serum levels of neuropeptides
{{output}}
The identification of biomarkers for pulmonary exacerbations in cystic fibrosis (CF) is inevitable. We aimed to evaluate the serum levels of substance p (SP), neuropeptide Y (NPY), and Pituitary Adenylate Cyclase Activating Polypeptide (PACAP), at time of pulm... ...
